U.S. Health Secretary Robert F. Kennedy Jr. announced plans to reform the National Vaccine Injury Compensation Program (VICP), pledging to address what he calls inefficiencies and corruption within the system. Kennedy, a long-time vaccine skeptic and former vaccine injury lawyer, criticized the program’s “Vaccine Court” for failing to quickly and fairly compensate individuals harmed by vaccines.
In a post on X, Kennedy said he is working with Attorney General Pam Bondi to restore the program to its “original congressional intent,” arguing that its current structure unfairly positions the Department of Health and Human Services (HHS), which he leads, as the defendant rather than vaccine manufacturers.
This move continues Kennedy’s sweeping efforts to reshape U.S. vaccine and health policy. In June, he dismissed all 17 members of the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices, replacing them with seven appointees, including figures with histories of questioning vaccine safety. One of these members previously earned significant fees as an expert witness against Merck’s Gardasil vaccine, a case in which Kennedy played a key role.
Kennedy is also reportedly considering removing members of another influential health advisory panel, the U.S. Preventive Services Task Force. His tenure at HHS has intensified scrutiny due to his longstanding promotion of vaccine skepticism, including discredited claims linking vaccines to autism and false statements about fetal cells in the measles vaccine.
The announcement comes amid one of the worst U.S. measles outbreaks in decades, further fueling debate over vaccine safety, public health policy, and Kennedy’s leadership approach.


Rafah Border Crossing to Reopen for Palestinians as Israel Coordinates with Egypt and EU
China Approves First Import Batch of Nvidia H200 AI Chips Amid Strategic Shift
FCC Chairman Raises Competition Concerns Over Netflix–Warner Bros. Discovery Deal
Panama Supreme Court Voids CK Hutchison Port Concessions, Raising Geopolitical and Trade Concerns
U.S. and Rwanda Sign $228 Million Health Partnership to Boost Self-Reliance
U.S. Eases Venezuela Oil Sanctions to Boost American Investment After Maduro Ouster
Pierre Poilievre Retains Conservative Leadership After Election Defeat in Canada
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors
Panama Supreme Court Voids Hong Kong Firm’s Panama Canal Port Contracts Over Constitutional Violations
SEC Drops Gemini Enforcement Case After Full Repayment to Earn Investors
U.S. and Israeli Military Leaders Hold Pentagon Talks as Tensions With Iran Escalate
Federal Judge Rules Trump Administration Unlawfully Halted EV Charger Funding
Trump Says Fed Pick Kevin Warsh Could Win Democratic Support in Senate Confirmation
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit 



